Scientists have released the biggest-ever artificial-intelligence (AI) model for biology, called Evo 2, which can write whole chromosomes and small genomes from scratch. This model has been trained on 128,000 genomes spanning the tree of life and can make sense of existing DNA, including hard-to-interpret ‘non-coding’ gene variants linked to disease. The developers see Evo 2 as a platform that others can adapt to their own uses, potentially creating a new ‘app store’ for biology.
Forecast for 6 months: Evo 2 will be widely adopted by researchers and scientists, leading to a significant increase in the number of breakthroughs in gene editing and DNA analysis. This will have a positive impact on the field of biology and medicine, with potential applications in treating genetic diseases.
Forecast for 1 year: As more researchers and scientists start using Evo 2, we can expect to see a significant increase in the number of new gene-editing tools and techniques being developed. This will lead to a greater understanding of the human genome and the development of new treatments for genetic diseases.
Forecast for 5 years: Evo 2 will have a profound impact on the field of biology and medicine, leading to significant advances in our understanding of the human genome and the development of new treatments for genetic diseases. We can expect to see the widespread adoption of gene editing technologies, leading to a new era of personalized medicine.
Forecast for 10 years: In the next decade, Evo 2 will have revolutionized the field of biology and medicine, leading to significant advances in our understanding of the human genome and the development of new treatments for genetic diseases. We can expect to see the widespread adoption of gene editing technologies, leading to a new era of personalized medicine and a significant improvement in human health.
